default author photo

Didier Lardinois

University of Basel - University Hospital Basel

Wilhelm-Klein-Strasse 27

Basel, 4025

Switzerland

SCHOLARLY PAPERS

3

DOWNLOADS

274

TOTAL CITATIONS

5

Scholarly Papers (3)

1.

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial

Number of pages: 32 Posted: 27 Jan 2021
University of Basel - University Hospital Basel, University of Basel - Department of Biomedicine, SAKK Coordinating Center, University of Basel - University Hospital Basel, Department of Oncology, HFR Fribourg – Hôpital fribourgeois, Department of Oncology, HFR Fribourg – Hôpital fribourgeois, Cantonal Hospital of St. Gallen, Cantonal Hospital of St. Gallen, University of Basel - University Hospital Basel, Cantonal Hospital Winterthur, Cantonal Hospital Winterthur, University Hospital Zurich, University Hospital Zurich, Department of Oncology, University Hospital Lausanne CHUV, Divison of Oncology/Haematology, Cantonal Hospital Graubünden, Divison of Oncology/Haematology, Cantonal Hospital Graubünden, University of Bern - Department of Medical Oncology, Department of Oncology/Haematology, Cantonal Hospital Aarau, Cantonal Hospital Baden, University of Geneva - Department of Oncology, Oncology Institute of Southern Switzerland, Division of Medical Oncology, St. Claraspital, Centre de Chimiothérapie Anti-Cancéreuse, SAKK Coordinating Center, SAKK Coordinating Center, Department of Thoracic Surgery, University Hospital Lausanne CHUV, Cantonal Hospital Winterthur and Independent
Downloads 147 (502,974)
Citation 4

Abstract:

Loading...

lung cancer; neoadjuvant; chemotherapy; immunotherapy; durvalumab; stage IIIA

2.

Integrated Single Cell Analysis Identifies CD39+ Tumor-Associated NK Cells with Cytotoxic Potential in Lung Cancer

Number of pages: 69 Posted: 18 Jul 2025
University of Basel - University Hospital Basel, Aix-Marseille University - Centre d'Immunologie de Marseille-Luminy, University of Basel - University Hospital Basel, University of Basel, ETH Zürich - Laboratory for Functional Immune Repertoire Analysis, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel, Aix-Marseille University - Centre d'Immunologie de Marseille-Luminy, Roche - Roche Pharma Research and Early Development, University of Basel - University Hospital Basel and Independent
Downloads 78 (816,709)
Citation 1

Abstract:

Loading...

tumor-associated NK cells, human lung cancer, single-nucleus RNA and ATAC sequencing

3.

Role of 18f-Fdg Pet/Ct in the Postoperative Follow-Up in Patients with Stage I-Iii Nsclc: A Retrospective Single-Institution Study

Number of pages: 23 Posted: 02 May 2022
affiliation not provided to SSRN, University of Basel - University Hospital Basel, University of Basel - Department of Clinical Research, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Basel - Clinic of Pneumology and Pulmonary Cell Research, University of Basel - University Hospital Basel, University of Basel - University Hospital Basel and University of Basel - University Hospital Basel
Downloads 49 (1,074,648)

Abstract:

Loading...

Resectable non-small cell lung cancer, FDG-PET/CT, surveillance, Recurrence, Second curatively intended treatment